Manufacturers Life Insurance Company, The Macrogenics Inc Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Macrogenics Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 121,278 shares of MGNX stock, worth $391,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,278

Previous 122,032 0.62%

Holding current value

$391,727

Previous $518,000 22.97%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.0 - $5.55 $2,262 - $4,184	-754 Reduced 0.62%	121,278 $399,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $8,218 - $45,960	2,483 Added 2.08%	122,032 $518,000
Q1 2024 May 14, 2024	BUY	$9.77 - $21.47 $948,520 - $2.08 Million	97,085 Added 432.18%	119,549 $1.76 Million
Q4 2023 Feb 13, 2024	SELL	$4.48 - $10.11 $14,712 - $33,201	-3,284 Reduced 12.75%	22,464 $216,000
Q3 2023 Nov 15, 2023	SELL	$4.48 - $6.19 $241 - $334	-54 Reduced 0.21%	25,748 $119,000
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $7,359 - $12,011	1,593 Added 6.58%	25,802 $138,000
Q4 2022 Aug 11, 2023	SELL	$3.34 - $6.98 $8,613 - $18,001	-2,579 Reduced 9.63%	24,209 $162,000
Q4 2022 Feb 13, 2023	SELL	$3.34 - $6.98 $8,613 - $18,001	-2,579 Reduced 9.63%	24,209 $162,000
Q3 2022 Aug 11, 2023	SELL	$3.01 - $5.22 $3,085 - $5,350	-1,025 Reduced 3.69%	26,788 $81,000
Q3 2022 Nov 03, 2022	SELL	$3.01 - $5.22 $3,085 - $5,350	-1,025 Reduced 3.69%	26,788 $93,000
Q2 2022 Aug 11, 2023	BUY	$2.25 - $9.99 $5,796 - $25,734	2,576 Added 10.21%	27,813 $82,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $5,796 - $25,734	2,576 Added 10.21%	27,813 $82,000
Q1 2022 Aug 11, 2023	BUY	$8.12 - $16.9 $8,347 - $17,373	1,028 Added 4.25%	25,237 $222,000
Q1 2022 May 20, 2022	SELL	$8.12 - $16.9 $50,027 - $104,120	-6,161 Reduced 19.62%	25,237 $222,000
Q4 2021 Feb 16, 2022	BUY	$15.91 - $21.88 $4,295 - $5,907	270 Added 0.87%	31,398 $504,000
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $39,795 - $57,859	-2,016 Reduced 6.08%	31,128 $652,000
Q2 2021 Aug 12, 2021	BUY	$20.49 - $35.63 $47,844 - $83,196	2,335 Added 7.58%	33,144 $890,000
Q1 2021 May 03, 2021	SELL	$18.99 - $33.2 $35,853 - $62,681	-1,888 Reduced 5.77%	30,809 $981,000
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $51,222 - $68,614	2,639 Added 8.78%	32,697 $747,000
Q3 2020 Nov 09, 2020	BUY	$24.69 - $31.6 $35,899 - $45,946	1,454 Added 5.08%	30,058 $757,000
Q2 2020 Aug 10, 2020	SELL	$5.2 - $29.12 $13,442 - $75,275	-2,585 Reduced 8.29%	28,604 $809,000
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $8,333 - $23,578	1,947 Added 6.66%	31,189 $182,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $5,493 - $8,478	-691 Reduced 2.31%	29,242 $318,000
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $57,488 - $78,091	3,962 Added 15.26%	29,933 $508,000
Q1 2019 May 13, 2019	BUY	$11.11 - $25.6 $10,321 - $23,782	929 Added 3.71%	25,971 $467,000
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $18,612 - $33,929	-1,584 Reduced 5.95%	25,042 $318,000
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $62,960 - $76,690	-3,269 Reduced 10.93%	26,626 $571,000
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $81,612 - $101,788	4,126 Added 16.01%	29,895 $617,000
Q1 2018 May 15, 2018	SELL	$18.89 - $32.46 $16,604 - $28,532	-879 Reduced 3.3%	25,769 $648,000
Q4 2017 Feb 08, 2018	BUY	$16.19 - $20.3 $2,477 - $3,105	153 Added 0.58%	26,648 $506,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $411,202 - $501,815	26,495	26,495 $489,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Macrogenics Inc Transaction History